key: cord-0780570-nexc4utd
authors: Torreggiani, M.; Ebikili, B.; Blanchi, S.; Piccoli, G.B.
title: Two episodes of SARS-CoV-2 infection in a patient on chronic hemodialysis. A note of caution.
date: 2021-01-21
journal: Kidney Int
DOI: 10.1016/j.kint.2021.01.003
sha: 8c757cc8dfe9b8127738ecebd8c0bcfba9677899
doc_id: 780570
cord_uid: nexc4utd

nan

Data from France in Dec. 2020 show that the cumulative incidence of SARS-Cov-2 infections reached 9% in the hemodialysis population, with a mortality of 15% (Bullettin of the French Agency of Biomedicine, 14 th Dec. 2020). The diagnosis may be challenging: false negatives are frequent and the persistence of positivity may be prolonged.

In this regard we report on a 89 year-old man on chronic hemodialysis for ESKD secondary to nephroangiosclerosis, and in the 3 rd month of palliative chemotherapy with 5-fluorouracil for metastatic liver cancer. He was screened because of a positive cluster in his nursing home. He was found positive to SARS-CoV-2 by a nasopharyngeal PCR test on November 5 th , 2020 (Ct RdRp 22; Ct N 20; Ct pos_ctrl 30; EurobioPlex SARS-CoV-2 Multiplex, Eurobio Scientific, Les Ulis, France) with no detectable anti-SARS-CoV-2 total IgG (Elecsys® Anti-SARS-CoV-2 S assay, Roche, Switzerland). He was hospitalized for surveillance from November 6 th to 13 th in the COVID Unit at the Centre Hospitalier Le Mans, where he remained asymptomatic and no imaging studies nor specific treatment were performed. Two PCR SARS-CoV-2 tests resulted negative on November 11 th and 13 th ; isolation measures were discontinued and he resumed treatment in his usual dialysis center.

On November 27 th , the patient presented shivers during the dialysis session; a chest CT-scan showed a right basal consolidation ( Figure 1A ) and amoxicillin/clavulanic acid was empirically started. On December 2 nd , his clinical conditions worsened with dyspnea and oxygen saturation of 90%. A chest CT-scan showed bilateral pulmonary honeycombing, highly suggestive for COVID-19 Lastly, this case may advise caution in evaluating the re-entry of SARS-CoV-2 infected patients amongst other hemodialyzed patients. In our case, a first false-positive test is unlikely, both due to the rarity of this occurrence and considering the antibody positivity timeframe. 2 However, two consecutive negative tests do not fully exclude a false negative result. Worth noting are the recent reports of shedding viable virus from immunocompromised patients up to two months from initial diagnosis 3 . For those reasons, which highlight the uncertainties in regards to this new disease, the a priori policy of discontinuing isolation without further testing after a symptom-free period of 20 days should probably be reconsidered on a case by case basis in hemodialysis patients. 4, 5 J o u r n a l P r e -p r o o f 

COVID-19 in a patient with end-stage renal disease on chronic incenter hemodialysis after evidence of SARS-CoV-2 IgG antibodies. Reinfection or inaccuracy of antibody testing

False-positive COVID-19 results: hidden problems and costs

Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer

European Centre for Disease Prevention and Control. Guidance for discharge and ending isolation of people with COVID-19

Discontinuation of transmission-based precautions and disposition of patients with COVID-19 in healthcare settings (interim guidance)